As we have demonstrated, TLR4/NF-κB/NEAT1 can be activated by LPS stimulation; are there any other dysregulated factors in lung cancer that can modulate this TLR4/NF-κB/NEAT1 axis? This evidence concerns the gene TLR4 and lung carcinoma.